This extensive lecture details the potential complications, pharmacological considerations, and essential management strategies related to local anesthesia in dental practice. The presentation systematically addresses local issues, such as injection failures due to technique or anatomical variations (e.g., facial palsy, hematomas, nerve injury), alongside severe systemic complications resulting from overdose or accidental intravascular injection. Key systemic risks covered include central nervous system excitation leading to seizures and subsequent respiratory depression, as well as cardiovascular effects like arrhythmia and circulatory arrest. The speaker emphasizes rigorous risk mitigation, including mandatory aspiration, slow fractionated injection techniques, and careful dose calculation based on body weight. Special attention is paid to managing high-risk patients (those with hypertension, coronary heart disease, and diabetes) and the judicious use of vasoconstrictors like adrenaline, while also outlining necessary emergency protocols (CPR, oxygen administration, administering anti-convulsants).
Local Anesthesia: Techniques, Complications, and Risk Management
0:10 Lecture Scope: The lecture focuses on local anesthesia techniques, pharmacology, and potential complications (local and systemic) in dental treatment.
0:43 Local Complications and Failure: Local complications can escalate to systemic problems (e.g., intravascular injection). Failure of anesthesia may result from incorrect application, anatomical variations, inappropriate methods, or expired anesthetic agents (0:01:36).
1:47 Mechanical Damage: Faulty technology or technique can cause direct mechanical tissue damage, such as necrosis (0:02:17) from applying too much pressure, or a cannula fracture.
2:38 Conduction Anesthesia Technique (Inferior Alveolar Nerve Block): The technique requires penetration 1 cm above the occlusal plane, aiming lateral to the raphe, and advancing to bone contact (0:04:27).
4:31 Aspiration is Mandatory: Aspiration is crucial to prevent intravascular injection. Experienced dentists have a positive aspiration rate of about 20% (0:04:43). The clinician must aspirate, rotate the cannula, and aspirate again before injection (0:05:08).
5:45 Risk of Facial Palsy: Injecting too far dorsally (especially when the patient is lying flat) risks applying the anesthetic near the facial nerve in the parotid gland, causing a peripheral facial palsy (0:06:03). This is temporary, requiring the patient to wait and use eye protection (0:07:04).
7:19 Conduction vs. Intraligamentary (IL) Injections: Conduction anesthesia is necessary for endocarditis hazards (as IL can push bacteria deep into tissue), row extractions, long-term preparations, and long interventions (>30 minutes).
8:55 Benefits of IL Injections: Immediate onset, short duration (no numb lip/cheek), and selective anesthesia for precise diagnosis (0:09:29). However, IL injections have a failure rate between 10% and 26% (0:10:10).
11:10 Hematomas: Hematomas can result from puncturing vessels, particularly if the injection is too far medial or too high near the pterygoid muscles. Conduction anesthesia is contraindicated in patients with hemorrhagic diathesis or those on anticoagulants (0:11:45).
12:49 Inflamed Tissue Challenge: Anesthetic effect is diminished in inflamed tissue due to lack of bicarbonate (needed for diffusion) and increased blood circulation (faster removal). Solution: Inject peripherally or tangentially to the inflammation (0:13:22).
14:15 Anatomical Variations: Anatomical variations (e.g., double split inferior alveolar nerves, retro-molar foramina, accessory nerves) occur in 1.4% to 6.6% of patients, potentially leading to incomplete blocks (0:15:27).
16:57 Post-Operative Risks: Patients must be warned about post-operative bite injuries and burn injuries due to prolonged numbness. Clinicians should use their own fingers as a guide to detect hot handpieces (0:17:48).
18:23 Nerve Injury Risk: Hitting and injecting into the mandibular or lingual nerve can cause long-lasting paresthesia or dysesthesia (0:18:47). If the patient reports a "lightning-like pain," the needle must be immediately retracted (0:21:13).
21:26 Systemic Complications: Systemic side effects stem from high plasma concentration (overdose or accelerated absorption), affecting CNS and cardiovascular function. Emergency equipment (oxygen, mask) must be mandatory (0:21:57).
23:49 Overdose and Dose Calculation: Surface anesthetics must be included in the maximum total dose. The dose limit for 4% Articaine with adrenaline is 7 mg/kg body weight (0:24:33). A 70 kg patient can safely receive 12.2 mL (0:24:54).
26:30 CNS Toxicity Sequence: Overdose starts with an excitation phase (unrest, tremor, nausea). A metallic taste is a serious warning sign (0:26:55). This progresses to seizures, loss of consciousness, and respiratory paralysis, which is life-threatening (0:27:38).
28:00 Cardiovascular Toxicity: Local anesthetics cause vasodilation, which, at high plasma levels, can lead to bradycardia, heart insufficiency, and circulatory arrest (0:28:37).
30:38 Emergency Procedures: Stop injection, give oxygen, intensive monitoring, and establish Venus access if trained. For convulsions, administer 10 mg Diazepam slowly IV (0:31:22). For arrest, perform CPR (0:31:51). Oxygen helps drive out CO2, maximizing plasma protein binding of the anesthetic to reduce systemic toxicity (0:32:17).
32:42 Injection Protocol: To prevent systemic effects, injection must be slow and fractionated (0:32:46).
33:21 Vasoconstrictors (Adrenaline): Vasoconstrictors prevent rapid flooding of the injection site, increasing duration/depth of anesthesia, reducing maximum serum concentration, and providing beneficial ischemia (0:33:53).
37:57 Contraindications for Vasoconstrictors: Relative contraindications include Coronary Heart Disease (risk of heart attack), hypertension, diabetes, and angle closure glaucoma.
39:34 Alternative Vasoconstrictor: Felypressin (Octapressin) is less effective but has no systemic cardiac side effects. Note: it requires an 8-minute latency period before starting the operation (0:39:36).
41:40 CHD Management: Pain from treatment can trigger an angina pectoris attack. Reduce risk via stress reduction, short morning sessions, effective anesthesia, and standby nitroglycerin (0:44:26). Avoid dental treatment 6 months after a heart attack (0:45:21).
47:27 Hypertension Management: Avoid long treatment times. Use vasoconstrictors, but limit the concentration (e.g., 1:200,000) (0:47:31). Avoiding vasoconstrictors can lead to failed anesthesia, pain, and subsequent high internal adrenaline output, worsening hypertension (0:47:52).
51:25 Absolute Contraindications: Uncontrolled hyperthyroidism (risk of severe arrhythmia), severe cardiac arrhythmias, and pathological epinephrine levels (pheochromocytoma) preclude the use of adrenaline-containing anesthetics (0:51:33).
56:01 Preservatives and Allergies: Recommend 2 mL glass ampules (preservative-free) to avoid sodium disulfite (antioxidant), which can cause problems for asthmatics (0:56:20). Allergic reactions require H1 and H2 receptor blocks (0:57:04).
58:36 Final Patient Safety Warning: Patients must be fully informed about temporary numbness, limited driving ability for at least 2 hours, and impairment of response capacity (0:58:58). The patient should remain in the practice for at least 30 minutes post-treatment (1:00:02).